Article PDF
Avoid common mistakes on your manuscript.
References
Levison ME: Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects. Infect Dis Clin North Am 1995, 9:483–495.
Hooper DC: Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001, 32(Suppl 1):S9-S15.
Tally FP, DeBruin MF: Development of daptomycin for grampositive infections. J Antimicrob Chemother 2000, 46:523–526.
Diekema DJ, Jones RN: Oxazolidinone antibiotics. Lancet 2001, 358:1975–1982.
Brisson-Noel A, Trieu-Cuot P, Courvalin P: Mechanism of action of spiramycin and other macrolides. J Antimicrob Chemother 1988, 22(Suppl B):13–23.
Smilack JD: The tetracyclines. Mayo Clin Proc 1999, 74:727–729.
Quinlivan EP, McPartlin J, Weir DG, Scott J: Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J 2000, 14:2519–2524.
Fuchs P, Barry A, Brown S: In vitro bactericidal activity of daptomycin against staphylococci. J Antimicrob Chemother 2002, 49:467–470.
Gradelski E, Valera L, Kolek B, et al.: Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams. Int J Antimicrob Agents 2001, 18:43–48.
Firsov A, Vostrov S, Lubenko I, et al.: In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:1604–1613.
Bozgogan B, Esel D, Whitener C, et al.: Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 2003, 52:864–868.
Mylonakis E, Calderwood SB: Infective endocarditis in adults. N Engl J Med 2001, 345:1318–1330.
Jacobs RF: Cefotaxime treatment of gram-negative enteric meningitis in infants and children. Drugs 1988, 35(Suppl 2):185–189.
McCracken GH Jr, Mize SG: A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr 1976, 89:66–72.
Lepper MH, Dowling HF: Treatment of pneumococcal meningitis with penicillin compared with penicillin plus aureomycin. Arch Intern Med 1951, 88:489.
Schimpff S, Satterlee W, Young VM, Serpick A: Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971, 284:1061–1065.
Bodey GP: Synergy. Should it determine antibiotic selection in neutropenic patients? Arch Intern Med 1985, 145:1964–1966.
Mattoes H, Banevicius M, Li D, et al.: Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae. Antimicrob Agents Chemother 2001, 45:2092–2097.
Dagan R, Klugman K, Craig W, et al.: Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001, 47:129–140.
Boccazzi A, Tonelli P, DeAngelis M, et al.: Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. Pediatr Infect Dis J 2000, 19:963–967.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alder, J., Eisenstein, B. The advance of bacterididal drugs in the treatment of infection. Curr Infect Dis Rep 6, 251–253 (2004). https://doi.org/10.1007/s11908-004-0042-1
Issue Date:
DOI: https://doi.org/10.1007/s11908-004-0042-1